Steven Luperchio Email

VP, Program Management and Portfolio Strategy . Cardurion Pharmaceuticals

Current Roles

Employees:
52
Revenue:
$8.1M
About
Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. Cardurion's product pipeline includes our lead clinical asset, CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. Cardurion has an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733. Additionally, Cardurion has a strong cardiovascular development partnership with Takeda which is fueling drug discovery and preclinical development work being conducted in our internal research laboratories.
Cardurion Pharmaceuticals Address
78 Blanchard Road
Boston, MA
United States
Cardurion Pharmaceuticals Email
Cardurion Pharmaceuticals Phone Numbers
617-863-8088

Past Companies

Cardurion PharmaceuticalsVice President, Program Management and Portfolio Strategy
Cardurion PharmaceuticalsExecutive Director, Program Management
ArsanisSenior Director, Clinical Development and Program Management

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.